Portal de Periódicos da CAPES

CD37: the comeback kid

2011; Elsevier BV; Volume: 118; Issue: 15 Linguagem: Inglês

10.1182/blood-2011-08-372268

1528-0020

Ian W. Flinn,

Lymphoma Diagnosis and Treatment

In this issue of Blood , Heider et al describe the preclinical development of a novel Fc-engineered monoclonal antibody targeting the B-cell antigen CD37, an antigen that may have very different properties then CD20.[1][1] In 1997, the first monoclonal antibody for treatment of cancer, rituximab,